Chitosan loaded microspheres as an ocular delivery system for acyclovir

International Journal of Pharmacy and Pharmaceutical Sciences

Volumn 4, Issue 1, 2012, Pages 125-132

  Selvaraj, S ^a   Karthikeyan, J ^a   Saravanakumar, N ^a  

^a Cherraan's College of Pharmacy   (India)

Author keywords

Acyclovir; Chitosan; Ionic gelation method; Microspheres; Ocular delivery

Indexed keywords

ACICLOVIR; CHITOSAN; MICROSPHERE; TRIPOLYPHOSPHATE;

ARTICLE; CONTROLLED STUDY; CRYSTALLIZATION; DIFFERENTIAL SCANNING CALORIMETRY; DIFFUSION; DRUG DELIVERY SYSTEM; DRUG DOSAGE FORM COMPARISON; GELATION; IN VITRO STUDY; INFRARED SPECTROSCOPY; MATHEMATICAL MODEL; MICROENCAPSULATION; MORPHOLOGY; PARTICLE SIZE; SUSTAINED DRUG RELEASE; ZETA POTENTIAL;

EID: 84855473244     PISSN: None     EISSN: 09751491     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. J. W. Shell. Opthalmic drug delivery systems. Drug Dev. Res.1985; 6: 245-261.
2. J. W. Shell. Ocular drug delivery systems: A review. J. Toxicol. Cut. and Ocular Toxicol 1982; 1(1): 49-63.
3. J. R. Robinson. Ocular drug delivery: Mechanisms of corneal drug transport and mucoadhesive delivery systems. S.T.P. Pharm. 1989; 5(12): 839-846.
4. T. F. Patton, and J. R. Robinson. Quantitative precorneal disposition of topically applied pilocarpine nitrate in rabbit eyes. J. Pharm. Sci. 1976; 65: 1295-1301.
5. R. W. Wood, V. H. E. Lee, J. Kreuter and J. R. Robinson. Ocular disposition of poly-hexyl-2-cyano [3-14C] acrylate nanoparticles in the albino rabbit. Int. J. Pharm. 1985;23: 175-183.
6. S.L. Ding. Recent developments in ophthalmic drug delivery. Pharm.Sci.Technol.Today 1998; 8:328-335.
7. Taskintuna, A. S. Banker, M. Flores-Aguilar, G. Bergeron-Lynn, K. A. Aldern, K. Y. Hostetler and W. R. Freeman. Evaluation of a novel lipid prodrug for intraocular drug delivery: effect of acyclovir diphosphate dimyristoylglycerol in a rabbit model with herpes simplex virus-1 retinitis. Retina 1997; 17:57-64.
8. Genta, B. Conti, P. Perugini, F. Pavanetto, A. Spadaro, and G. Puglisi. Bioadhesive microspheres for ophthalmic administration of acyclovir. J. Pharma. Pharmacol 1997; 49:737-742.
9. Harmia T, Speiser P, Kreuter J. A solid colloidal drug delivery system for the eye: encapsulation of pilocarpin in nanoparticles. J Microencapsulation 1986; 3: 3-12.
10. Losa C, Calvo P, Vila-Jato JL, Alonso MJ. Improvement of ocular penetration of a amikacin sulphate by association to poly-(butylcyanoacrylate) nanoparticles. J Pharm Pharmacol.1991;43: 548-552.
11. Losa C, Marchal-Heussler L, Orallo F, Vila-Jato JL, Alonso MJ. Design of new formulations for topical ocular administration: polymeric nanocapsules containing metipranolol. Pharmacol Res 1993;10:80-87.
12. Calvo P, Thomas C, Alonso MJ, Vila-Jato JL, Robinson JR. Study of the mechanism of interaction of poly-e-caprolactone nanocapsules with the cornea by confocal laser scanning microscopy. Int J Pharmacol 1994;103:283-291.
13. Calvo P, Sánchez A, Martínez J, et al. Polyester nanocapsules as new topical ocular delivery systems for cyclosporine A. Pharmacol Res. 1996;13:311-315.
14. Alonso MJ, Sánchez A. Biodegradable nanoparticles as new transmucosal drug carriers. Sönke Svenson eds. Carrier-Based Drug Delivery. ACS Symposium Series Washington DC. 2004;283-295.
15. Hirano S, Seino H, Akiyama I, Nonaka I. Chitosan: a biocompatible material for oral and intravenous administration. Gebelein CG Dunn RL eds. Progress in Biomedical Polymers Plenum Press New York. 1990; 283-289.
16. Lehr CM, Bouwstra JA, Schacht EH, Junginger HE. In vitro evaluation of mucoadhesive properties of chitosan and some other natural polymers. Int J Pharm.1992;78:43-48.
17. Felt O, Buri P, Gurny R. Chitosan: a unique polysaccharide for drug delivery. Drug Dev Ind Pharm. 1998; 24:979-993.
18. Alonso MJ, Sánchez A. The potential of chitosan in ocular drug delivery. J Pharm Pharmacol 2003; 55:1451-1463.
19. D. A. Jabs. Acyclovir for recurrent herpes simplex virus ocular disease. N. Engl. J. Med 1998;339:300-306.
20. Y. Ohashi. Treatment of herpetic keratitis with acyclovir: benefits and problems. Ophthalmologica. 1997; 211:29-32.
21. G. W. Aylward, C. M. Claoue, R. J. Marsh, and N. Yasseem. Influence of oral acyclovir on ocular complications of herpes zoster ophthalmicus. Eye. 1994; 8:70-74.
22. D. Pavan-Langston. Herpetic infections. In G. Smolin and R. A.Thoft (eds.), the Cornea, 3rd ed., Little Brown, Boston, Massachusetts. 1994; pp. 183-214.
23. G. Wagstaff, D. Faulds, and K. L. Goa. Aciclovir: a reappraisal of its antiviral activity, pharmacokinetic properties and therapeutic efficacy. Drugs.1994; 47:153-205.
24. Product Information Leaflet of Cipla given in the Acivir® eye ointment pack.
25. Genta I, Conti B, Perugini P, Pavanetto F, Spadaro A, Puglisi G. Bioadhesive microspheres for ophthalmic administration of acyclovir. J Pharm Pharmacol 1997; 49:737-742.
26. Kas HS. Chitosan: properties, preparation and application to microparticulate systems. J Microencapsul. 1997; 14:689-711.
27. He P, Davis SS, Illum L. In vitro evaluation of mucoadhesive properties of chitosan microspheres. Int J Pharm. 1998;166:75-88
28. Knapczyk, J., Kro ́wczynski, L., Krzck, J., Brzeski, M., Nirnberg, E., Schenk, D., Struszcyk, H. Requirements of chitosan for pharmaceutical and biomedical applications. In: Skak-Braek, G., Anthonsen, T., Sandford, P. (Eds.), Chitin and Chitosan: Sources, Chemistry, Biochemistry, Physical Properties and Applications. Elsevier, London 1989, pp. 657-663.
29. Artursson, P., Lindmark, T., Davis, S.S., Illum, L. Effect of chitosan on the permeability of monolayers of intestinal epithelial cells (Caco-2). Pharm. Res 1994; 11:1358-1361.
30. Bodmeier R, Paeratakul O. Spherical agglomerates of water-insoluble drugs. J Pharm Sci 1989;78:964-967.
31. Shiraishi S, Imai T, Otagiri M. Controlled release of indomethacin by chitosan-polyelectrolyte complex: optimization and invivo/invitro evaluation. Control Release 1993; 25:217-225.
32. Shu XZ, Zhu KJ. A novel approach to prepare tripolyphosphate/chitosan complex beads for controlled release drug delivery. Int J Pharm 2000; 201:51-58.
33. Sudha Rathod and S. G. Deshpande. Albumin Microspheres as an Ocular Delivery System for Pilocarpine Nitrate. Indian J Pharm Sci. 2008 Mar-Apr; 70(2): 193-197.
34. Yadav KS, Sathish CS, Shivkumar HG. Preparation and evaluation of chitosan -Poly (Acrylic acid) Hydrogels as stomach specific delivery for amoxicillin and metronidazole. Indian J Pharm Sci. 2007; 69(1):91-95.
35. Alonso MJ. Sanchez, A. Biodegradable nanoparticles as new transmucosal drug carrier. Carrier Based Drug Delivery. 2004:283-295.
36. Lehr C.M, Bouwstra J.A, Schacht EH, Junginger HE. Invitro evaluation of mucoadhesive properties of chitosan and some other natural polymers. Int J Pharm 1992;78:43-48.
37. Feltt O, Buri P, Gurny R. Chitosan; a unique polysaccharide for drug delivery. Drug Dev Ind Pharm. 1998; 24:979-993.
38. Patil SB, Murthy RSR. Preparation and In vitro evaluation of mucoadhesive chitosan microspheres of Amlodipine Besylate for nasal administration. Ind J Pharm Sci 2006; 68:64-67.
39. Denkbas EB, Seyyal M, Piskins E. 5-Fluorouracil loaded chitosan microspheres for chemoembolization. J Microencapsulation. 1999; 16:741-49.
40. V. C. F. Mosqueira, P. Legrand, R. Gref, and G. Barratt. In-vitro release kinetic studies of PEG-modified nanocapsules and nanospheres loaded with a lipophilic drug: halofantrine base. Control. Rel. Bioact. Mater.1999;26:1074-1075.
41. V. C. F. Mosqueira, P. Legrand, H. Pinto-Alphandary, F. Puisieux, and G. Barratt. Poly (D, L-lactide) nanocapsules prepared by a solvent displacement process:influence of the composition on physicochemical and structural properties. J. Pharm. Sci. 2000; 89:614-626.
42. Mi FL, Shyu SS, Wong T, Jang SF, Lee ST, Lu KT. Chitosan-polyelectrolyte complexation for the preparation of gel beads and controlled release of anticancer drug. II. Effect of pH-dependent ionic cross-linking or interpolymer complex using tripolyphosphate or polyphosphate reagent. J Appl Polym Sci. 1999; 74:1093-1107.
43. Yan Wu, Wuli Yang, and Shoukuan Fu, Chitosan nanoparticles as a novel delivery system for ammonium glycyrrhizinate, International journal of pharmaceutics. 2005; 235-245.
44. Zhou, S.B., Deng, X.M., Li, X.H.,. Investigation on a novel core-coated microspheres protein delivery system. J. Control. Release 2001; 75:27-36.
45. Dredan J, Antal I, Racz I. Evaluation of mathematical models describing drug release from lipophilic matrices. Int J Pharm. 1996; 145:61-64.
46. Peppas NA. Analysis of fickian and non-fickian drug release from polymers. Pharm Acta Helv. 1985; 60:110-11.
47. Siepmann J, Peppas NA. Modelling of drug releases from delivery systems based on hydroxypropyl methyl cellulose (HPMC). Adv Drug Del Rev.2001;48:139-57.
48. Govender S, Pillay V, Chetty DJ, Essack SY, Dangor CM, Govender T. Optimization and characterization of bioadhesive controlled release tetracycline microspheres. Int J Pharm 2005; 306:24-40.
49. Dhawan S, Singla AK. Nifedipine loaded chitosan microspheres prepared by emulsification phaseseparation. Biotechnic Histochem. 2003; 78:243254.
50. Lehr, C.M., Bouwstra, J.A., Schacht, E., Junginger, H.E., In vitro evaluation of mucoadhesive properties of chitosan and some other natural polymers. Int. J. Pharm 1992; 78:43-48.
51. Gundu Z, K., O Zdemir, O., Topical cyclosporine treatment of keratoconjunctivitis sicca in secondary Sjogren's syndrome. Acta Ophthalmol. 1994; 72:438-442.